Neoplasms, Plasma Cell [clinicaltrials_resource:aa41b92d39b7feaa4386ec3c5f5bf8bf]
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00001561]Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia [clinicaltrials:NCT00001623]Comparing Treatments for Multiple Myeloma [clinicaltrials:NCT00001750]Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002502]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]clinicaltrials:NCT00002548Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [clinicaltrials:NCT00002556]Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [clinicaltrials:NCT00002599]High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [clinicaltrials:NCT00002630]Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease [clinicaltrials:NCT00002652]Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [clinicaltrials:NCT00002653]clinicaltrials:NCT00002657clinicaltrials:NCT00002678Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [clinicaltrials:NCT00002742]Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation [clinicaltrials:NCT00002787]High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [clinicaltrials:NCT00002810]High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [clinicaltrials:NCT00002818]clinicaltrials:NCT00002850Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00002878]Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [clinicaltrials:NCT00002907]Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002989]Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [clinicaltrials:NCT00003007]Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [clinicaltrials:NCT00003077]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]clinicaltrials:NCT00003116Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Interleukin-12 in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003149]Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation [clinicaltrials:NCT00003153]Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [clinicaltrials:NCT00003163]Bryostatin and Vincristine in B-Cell Malignancies [clinicaltrials:NCT00003166]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003331]Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [clinicaltrials:NCT00003341]
condition browse [clinicaltrials_vocabulary:condition-browse]
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00001561]Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia [clinicaltrials:NCT00001623]Comparing Treatments for Multiple Myeloma [clinicaltrials:NCT00001750]Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002502]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]clinicaltrials:NCT00002548Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [clinicaltrials:NCT00002556]Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [clinicaltrials:NCT00002599]High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [clinicaltrials:NCT00002630]Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease [clinicaltrials:NCT00002652]Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [clinicaltrials:NCT00002653]clinicaltrials:NCT00002657clinicaltrials:NCT00002678Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [clinicaltrials:NCT00002742]Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation [clinicaltrials:NCT00002787]High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [clinicaltrials:NCT00002810]High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [clinicaltrials:NCT00002818]clinicaltrials:NCT00002850Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00002878]Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [clinicaltrials:NCT00002907]Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002989]Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [clinicaltrials:NCT00003007]Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [clinicaltrials:NCT00003077]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [clinicaltrials:NCT00003107]clinicaltrials:NCT00003116Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Interleukin-12 in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003149]Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation [clinicaltrials:NCT00003153]Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [clinicaltrials:NCT00003163]Bryostatin and Vincristine in B-Cell Malignancies [clinicaltrials:NCT00003166]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003331]Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [clinicaltrials:NCT00003341]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Neoplasms, Plasma Cell [clinicaltrials_resource:aa41b92d39b7feaa4386ec3c5f5bf8bf]
Bio2RDF identifier
aa41b92d39b7feaa4386ec3c5f5bf8bf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:aa41b92d39b7feaa4386ec3c5f5bf8bf
identifier
clinicaltrials_resource:aa41b92d39b7feaa4386ec3c5f5bf8bf
title
Neoplasms, Plasma Cell
@en
type
label
Neoplasms, Plasma Cell [clinicaltrials_resource:aa41b92d39b7feaa4386ec3c5f5bf8bf]
@en
Neoplasms, Plasma Cell